French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
데이터 추가 비고
조치
batches: 00WC057A (Expiration 10/2003), 00WC066A (Expiration 11/2003), 00WC066B (Expiration 11/2003), 01WC009A (Expiration 03/2004), 01WC023B (Expiration 05/2004), 01WC045A (Expiration 09/2004) , of the pharmaceutical specialty called XENETIX 300, solution for injection in a 200 ml bottle, from the GUERBET laboratory, are withdrawn from the market, following a non-conformity of the AMM: presence of a notice in Greek language. This does not call into question the quality of the contrast product.